Trial Profile
Comparison of Dapagliflozin (DAPA) and Once-weekly Exenatide (EQW), Co-administered or Alone, DAPA/ Glucophage (DAPA/MET ER) and Phentermine/Topiramate (PHEN/TPM) ER on Metabolic Profiles and Body Composition in Obese PCOS Women
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary) ; Dapagliflozin/metformin (Primary) ; Exenatide (Primary) ; Phentermine/topiramate
- Indications Obesity
- Focus Pharmacodynamics
- 12 Oct 2020 Status changed from active, no longer recruiting to completed.
- 18 May 2020 Planned primary completion date changed from 1 Apr 2020 to 30 Jul 2020.
- 18 May 2020 Status changed from recruiting to active, no longer recruiting.